Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
Browsing: Viral > Herpes
In this exclusive opinion piece, the authors discuss how a neuroattenuated varicella zoster virus (VZV) vaccine could provide promising protection against VZV infection.
In this editorial the authors discuss how targeting the human TREX complex could prevent herpesvirus replication, highlighting their own work targeting herpesvirus lytic replication through inhibition of the hTREX complex.
Researchers have demonstrated that nanoparticles, such as those from burning fossil fuels, appear to reactivate latent herpesviruses in lung tissue.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.
Varicella zoster virus causes chickenpox and zoster infections – this research aimed to investigate the distribution of viral genotypes among patients.
In this editorial the authors discuss the potential of zinc oxide nanoparticles as an immunotherapy against genital herpes infections.